▁Chron 9.296875
ic 0.548828125
▁pain 2.759765625
▁is 1.1630859375
▁still 6.71875
▁considered 3.98828125
▁to 1.927734375
▁be 0.032806396484375
▁an 2.6796875
▁extreme 7.26171875
▁issue 4.02734375
▁among 3.62109375
▁at 9.375
▁least 0.15576171875
▁ 0.390380859375
8 3.47265625
% 2.19140625
▁of 0.122314453125
▁the 0.5146484375
▁residents 6.63671875
▁of 0.7392578125
▁progress 12.6484375
ive 0.319580078125
▁countries 0.91650390625
. 0.63525390625
▁The 2.115234375
▁introduction 7.74609375
▁of 0.0309906005859375
▁the 2.357421875
▁study 7.31640625
▁describes 7.28515625
▁the 0.5732421875
▁apparent 8.9140625
▁link 4.6796875
▁between 0.2406005859375
▁pain 2.71875
▁and 0.2958984375
▁dem 7.14453125
oral 3.390625
ization 0.12353515625
. 1.046875
▁Chron 4.515625
ic 0.0032253265380859375
▁pain 0.11016845703125
▁is 1.0947265625
▁always 5.6015625
▁accompanied 2.982421875
▁by 0.1500244140625
▁negative 4.1484375
▁emot 0.9111328125
ional 1.4072265625
▁experiences 2.984375
▁and 2.080078125
▁blocks 11.3046875
▁a 3.33984375
▁person 0.69140625
’ 0.876953125
s 0.0010728836059570312
▁ability 1.3876953125
▁to 0.037200927734375
▁receive 6.84375
▁joy 3.728515625
▁and 1.376953125
▁satisfaction 3.25390625
▁from 0.86767578125
▁life 0.79443359375
. 0.2281494140625
▁The 1.6455078125
▁research 2.693359375
▁investig 5.40625
ates 0.3876953125
▁the 0.38818359375
▁development 6.15234375
▁of 0.145751953125
▁de 3.83984375
pression 0.45849609375
▁and 1.357421875
▁anx 1.6201171875
iety 0.0010986328125
▁among 1.603515625
▁patients 1.4833984375
▁receiving 5.83203125
▁ph 5.4765625
arma 3.240234375
ce 0.01218414306640625
ut 6.61611557006836e-05
ical 0.006450653076171875
▁op 4.64453125
io 0.097900390625
ids 0.440185546875
▁and 2.4921875
▁medical 4.0546875
▁mar 1.744140625
iju 0.0010824203491210938
ana 4.839897155761719e-05
▁( 2.96484375
MM 1.2998046875
) 2.884765625
▁as 2.44140625
▁severe 9.984375
▁pain 0.7822265625
kill 2.658203125
ers 0.0005207061767578125
. 0.21630859375
▁It 3.2578125
▁comp 4.984375
ares 0.0084686279296875
▁the 0.58935546875
▁effic 4.296875
acy 0.0018758773803710938
▁of 0.2064208984375
▁pres 6.0859375
cri 1.9169921875
ptions 1.451171875
▁and 1.9296875
▁exam 4.49609375
ines 0.00980377197265625
▁the 0.473388671875
▁possibility 3.95703125
▁of 0.132080078125
▁post 8.203125
- 0.58740234375
tre 1.96875
at 0.001781463623046875
ment 0.004730224609375
▁de 1.6416015625
pression 0.08135986328125
. 1.384765625
▁There 5.67578125
▁is 1.146484375
▁currently 6.203125
▁a 1.1640625
▁severe 5.1171875
▁lack 1.6416015625
▁of 0.0124969482421875
▁information 2.236328125
▁about 1.205078125
▁the 0.58447265625
▁effects 3.2109375
▁of 0.06561279296875
▁op 3.447265625
i 3.546875
ates 0.01343536376953125
. 3.322265625
▁They 5.28515625
▁manage 8.640625
▁pain 3.125
▁successfully 5.80859375
, 0.9716796875
▁but 0.19140625
▁the 2.4609375
▁past 9.1484375
▁few 2.455078125
▁dec 1.341796875
ades 0.0011491775512695312
▁indicated 7.15625
▁the 1.765625
▁growing 3.634765625
▁concern 3.36328125
▁regarding 2.779296875
▁op 2.6796875
iate 1.224609375
▁ab 1.5693359375
use 0.0152587890625
▁in 3.92578125
▁forms 8.90625
▁of 0.251708984375
▁over 3.2265625
d 0.1046142578125
ose 0.30859375
▁and 0.6953125
▁add 0.70361328125
iction 0.01995849609375
. 0.12054443359375
▁A 4.25390625
▁more 4.91796875
▁manage 7.9453125
able 0.0005421638488769531
▁and 2.013671875
▁sa 2.0625
fer 0.00016701221466064453
▁alternative 1.3134765625
▁might 5.078125
▁be 0.1187744140625
▁medical 1.8916015625
▁mar 0.18603515625
iju 0.0006275177001953125
ana 9.906291961669922e-05
. 0.849609375
▁However 3.68359375
, 0.0031299591064453125
▁the 1.703125
▁legal 4.015625
▁status 1.1298828125
▁and 3.017578125
▁novel 9.7109375
ty 0.1376953125
▁of 0.1502685546875
▁this 2.287109375
▁drug 1.40625
▁do 4.40234375
▁not 0.01220703125
▁allow 0.673828125
▁finding 6.98828125
▁a 2.35546875
▁large 2.541015625
▁number 0.81005859375
▁of 0.0022735595703125
▁studies 1.302734375
▁on 1.7568359375
▁its 0.81005859375
▁effect 2.3984375
iveness 0.202392578125
. 0.6416015625
▁Specifically 8.96875
, 0.03997802734375
▁it 2.6171875
▁concerns 5.26171875
▁the 0.8095703125
▁emot 6.42578125
ional 0.018218994140625
▁condition 4.58203125
▁of 0.221923828125
▁patients 0.65234375
▁experien 5.3046875
cing 0.0001722574234008789
▁chron 0.8134765625
ic 0.00037097930908203125
▁pain 0.05133056640625
. 0.378173828125
▁This 3.0078125
▁research 1.814453125
▁paper 3.951171875
▁a 2.013671875
ims 0.0005292892456054688
▁to 0.10504150390625
▁analyze 3.19140625
▁levels 10.1484375
▁of 0.0240936279296875
▁de 0.5185546875
pression 0.0250091552734375
▁and 0.1856689453125
▁anx 0.0253753662109375
iety 0.0004305839538574219
▁among 0.7451171875
▁people 2.6796875
▁receiving 2.25
▁ther 6.625
apy 0.111572265625
▁by 4.5546875
▁comparing 8.3671875
▁the 1.5078125
▁effects 2.19140625
▁of 0.0268402099609375
▁ph 2.841796875
arma 0.0309906005859375
ce 0.0027313232421875
ut 0.00010335445404052734
ical 0.003261566162109375
▁op 0.11114501953125
io 0.4873046875
ids 0.031982421875
▁and 0.255615234375
▁MM 0.509765625
. 0.287841796875
▁The 1.4736328125
▁study 2.00390625
▁was 3.544921875
▁conducted 0.70947265625
▁in 1.3017578125
▁the 1.3779296875
▁form 2.580078125
▁of 0.0020885467529296875
▁collection 11.625
▁and 0.70068359375
▁analysis 0.411865234375
▁of 0.0103302001953125
▁statistical 3.748046875
▁data 0.1298828125
. 1.1982421875
▁Part 5.5234375
icip 0.2186279296875
ants 0.0565185546875
▁were 0.76953125
▁rec 3.75
ru 0.0010166168212890625
ited 0.00016927719116210938
▁for 4.24609375
▁six 6.90625
▁months 0.370849609375
▁at 4.04296875
▁two 2.619140625
▁major 4.0390625
▁pain 2.662109375
▁relief 3.923828125
▁cent 0.85595703125
ers 0.031829833984375
▁in 0.64306640625
▁Israel 5.4765625
. 0.314453125
▁The 1.1279296875
▁research 2.44140625
ers 1.970703125
▁used 1.998046875
▁The 6.9140625
▁De 2.87109375
pression 0.0201263427734375
▁Module 6.890625
▁of 0.78759765625
▁the 0.23974609375
▁Pat 3.3203125
ient 0.00905609130859375
▁Health 0.032745361328125
▁Question 0.01800537109375
naire 0.023406982421875
▁and 2.494140625
▁the 0.880859375
▁General 1.1826171875
ized 0.63037109375
▁An 0.00481414794921875
x 8.177757263183594e-05
iety 0.00042557716369628906
▁Dis 0.1888427734375
order 0.0193939208984375
▁Sc 1.3681640625
ale 0.003070831298828125
▁to 0.9365234375
▁interview 7.78515625
▁participants 2.482421875
, 4.38671875
▁evaluate 4.484375
▁their 0.6044921875
▁answers 3.943359375
, 0.30419921875
▁and 0.0369873046875
▁conduct 4.75
▁the 1.8623046875
▁study 2.359375
. 0.08062744140625
▁To 5.19140625
▁specifically 10.6015625
▁evaluate 3.16015625
▁and 4.87890625
▁compare 0.5390625
▁the 0.385986328125
▁prob 9.78125
abilities 0.060821533203125
▁of 0.072998046875
▁de 0.84619140625
pression 0.0330810546875
▁or 4.37890625
▁anx 0.045074462890625
iety 0.0005936622619628906
▁among 1.3154296875
▁the 2.1171875
▁diverse 9.78125
▁groups 0.8232421875
, 0.80078125
▁the 0.46240234375
▁study 2.56640625
▁used 1.404296875
▁multiple 5.34765625
▁log 0.5703125
istic 0.0242462158203125
▁regression 0.26904296875
▁analysis 1.3447265625
▁and 2.732421875
▁chose 8.5625
▁medical 6.234375
▁mar 0.07647705078125
iju 0.0008320808410644531
ana 4.315376281738281e-05
▁as 0.452392578125
▁the 0.81640625
▁control 2.802734375
▁group 0.6083984375
. 0.26025390625
▁This 3.599609375
▁type 4.4921875
▁of 0.004123687744140625
▁study 2.82421875
▁is 1.501953125
▁the 3.744140625
▁most 1.322265625
▁reve 8.2578125
aling 0.0007977485656738281
▁and 1.546875
▁inclus 7.1953125
ive 0.0009732246398925781
, 2.580078125
▁as 1.2568359375
▁it 0.267578125
▁contains 5.171875
▁direct 6.73828125
▁responses 5.57421875
▁from 0.8193359375
▁a 3.734375
▁large 1.142578125
▁number 0.5048828125
▁of 0.0027618408203125
▁participants 0.9677734375
. 0.77490234375
▁All 5.34765625
▁tools 7.93359375
▁in 5.15625
▁the 0.62158203125
▁form 5.5
▁of 0.026885986328125
▁question 0.7314453125
na 0.01236724853515625
ires 0.0001863241195678711
▁and 1.3759765625
▁scales 2.76171875
▁have 3.271484375
▁already 4.42578125
▁been 0.341064453125
▁used 2.42578125
▁and 1.7958984375
▁proved 2.4921875
▁their 1.4462890625
▁effic 2.603515625
acy 0.00267791748046875
▁for 3.578125
▁collect 4.078125
ing 0.004241943359375
▁analyt 7.26171875
ical 0.09613037109375
▁data 0.1904296875
. 0.38916015625
▁It 3.728515625
▁helps 4.36328125
▁to 0.62890625
▁system 6.66796875
at 0.6240234375
ize 0.001857757568359375
▁and 1.265625
▁class 4.81640625
ify 0.0016698837280273438
▁distinct 8.203125
▁kinds 6.41796875
▁of 0.0168609619140625
▁information 2.169921875
▁for 3.974609375
▁subsequent 5.02734375
▁un 8.625
comp 4.203125
licated 0.021453857421875
▁services 12.421875
. 0.57568359375
▁Thus 4.76171875
, 0.007770538330078125
▁research 4.6796875
ers 0.37841796875
▁can 1.6435546875
▁compare 2.625
▁the 0.99072265625
▁effects 2.908203125
▁of 0.10174560546875
▁medic 3.81640625
ations 0.669921875
▁on 1.5380859375
▁patients 2.005859375
▁of 4.28125
▁diverse 3.14453125
▁age 1.9951171875
▁groups 2.0546875
, 0.73681640625
▁background 3.89453125
s 0.12042236328125
, 0.0160064697265625
▁physical 5.5703125
▁conditions 1.29296875
, 0.03509521484375
▁emot 6.27734375
ional 0.02825927734375
▁states 1.310546875
, 0.0416259765625
▁and 0.379638671875
▁so 2.671875
▁on 0.19189453125
. 0.06427001953125
▁The 0.97802734375
▁analysis 3.64453125
▁of 0.98779296875
▁any 8.6796875
▁human 6.81640625
▁reaction 3.90625
▁has 4.8203125
▁a 1.8271484375
▁high 2.990234375
▁potential 3.18359375
▁of 2.28125
▁subject 3.990234375
iveness 3.638671875
▁and 1.203125
▁bias 1.955078125
, 1.6142578125
▁especially 2.76171875
▁regarding 3.69921875
▁people 4.86328125
▁in 3.716796875
▁severe 2.521484375
▁pain 0.57958984375
▁and 2.33984375
▁un 5.640625
stable 0.91748046875
▁emot 0.68310546875
ional 0.090576171875
▁condition 2.515625
. 0.055694580078125
▁Perhaps 9.0078125
▁some 5.3828125
▁patients 2.177734375
▁tend 4.53125
▁to 0.00888824462890625
▁ex 1.9599609375
agger 0.00884246826171875
ate 0.00140380859375
▁their 0.9443359375
▁de 3.220703125
press 1.7412109375
ive 0.0623779296875
▁state 2.5078125
▁or 1.630859375
▁vice 5.6171875
▁vers 0.0238800048828125
a 2.8848648071289062e-05
, 1.1015625
▁de 7.33203125
- 2.521484375
emph 0.423095703125
as 0.0022373199462890625
ize 0.057952880859375
▁serious 6.76171875
▁difficulties 5.59765625
. 0.791015625
▁Because 6.328125
▁the 2.9453125
▁survey 5.0390625
▁responses 6.72265625
▁were 1.4775390625
▁thoroughly 8.140625
▁anonymous 2.970703125
, 0.28466796875
▁the 1.203125
▁research 1.0263671875
ers 0.198974609375
▁were 2.4140625
▁unable 3.27734375
▁to 0.00160980224609375
▁carefully 7.9765625
▁analyze 2.6640625
▁each 2.44921875
▁patient 2.478515625
’ 0.55908203125
s 0.0011434555053710938
▁reaction 3.9296875
▁and 1.3974609375
▁compare 3.712890625
▁it 0.85009765625
▁to 0.6103515625
▁the 0.99609375
▁actual 4.40625
▁states 7.6328125
▁of 0.6591796875
▁condition 7.0390625
. 0.35595703125
▁More 5.9921875
▁accurate 3.3359375
▁answers 4.43359375
▁could 1.890625
▁be 0.70166015625
▁obtained 0.9970703125
▁by 1.451171875
▁professional 6.0390625
▁psych 1.109375
olog 0.394775390625
ists 0.0012884140014648438
▁via 7.15234375
▁personal 2.677734375
▁communication 4.36328125
▁and 1.9443359375
▁behavior 6.29296875
al 0.250244140625
▁analysis 2.076171875
. 0.299072265625
▁However 1.501953125
, 0.0004391670227050781
▁this 1.5224609375
▁method 2.263671875
▁of 2.482421875
▁research 1.958984375
▁is 1.0732421875
▁way 6.0546875
▁more 0.94287109375
▁resource 4.61328125
- 0.289306640625
int 1.3876953125
ensive 0.0233154296875
▁and 0.4248046875
▁energy 10.6796875
- 0.0684814453125
consum 0.366943359375
ing 0.0016222000122070312
. 0.72412109375
▁All 5.515625
▁patients 4.10546875
▁experienced 5.1484375
▁chron 1.2724609375
ic 0.00021135807037353516
▁pain 0.10211181640625
▁for 2.986328125
▁at 0.83544921875
▁least 0.0021648406982421875
▁ 1.833984375
3 1.6650390625
▁months 0.290771484375
. 1.421875
▁The 1.486328125
▁study 1.9033203125
▁included 2.404296875
▁ 0.859375
8 2.93359375
9 2.517578125
0 3.169921875
▁participants 1.505859375
, 1.3896484375
▁of 2.69140625
▁which 0.41259765625
▁ 0.10943603515625
4 1.2197265625
7 2.650390625
4 2.63671875
▁( 3.13671875
5 0.0921630859375
9 4.8671875
%) 0.73828125
▁were 0.8134765625
▁treated 3.21875
▁sole 6.7109375
ly 0.00011098384857177734
▁with 0.32470703125
▁op 1.400390625
io 0.35791015625
ids 0.135009765625
, 0.529296875
▁ 0.87353515625
3 1.26171875
2 2.212890625
9 2.4765625
▁( 0.049346923828125
4 2.453125
1 1.1337890625
%) 0.054443359375
▁were 1.5458984375
▁treated 0.80029296875
▁with 0.34130859375
▁MM 0.544921875
, 0.338134765625
▁and 0.10321044921875
▁ 0.2177734375
7 2.201171875
7 2.49609375
▁( 0.10809326171875
8 1.927734375
. 0.9052734375
6 2.4453125
%) 0.0823974609375
▁acquired 10.421875
▁both 0.63330078125
▁( 4.875
Fe 9.125
ing 1.24609375
old 0.41552734375
▁et 1.1220703125
▁al 0.02252197265625
., 0.1490478515625
▁ 0.013397216796875
2 0.008331298828125
0 0.0002739429473876953
1 0.325927734375
7 1.7080078125
). 0.05133056640625
▁Part 4.59375
icip 0.07281494140625
ants 0.029541015625
▁were 1.02734375
▁rec 3.103515625
ru 0.0008106231689453125
ited 4.374980926513672e-05
▁for 2.53125
▁six 0.51904296875
▁months 0.01027679443359375
▁at 0.76806640625
▁two 0.1343994140625
▁major 0.1492919921875
▁pain 0.0460205078125
▁relief 0.04656982421875
▁cent 0.0198822021484375
ers 0.0006241798400878906
▁in 0.061737060546875
▁Israel 0.021240234375
. 0.283203125
▁The 0.95068359375
▁remaining 9.2578125
▁ten 6.828125
▁participants 1.4794921875
▁who 4.03515625
▁did 2.25390625
▁not 0.005992889404296875
▁receive 2.560546875
▁ph 4.1953125
arma 0.0726318359375
ce 0.0009183883666992188
ut 8.463859558105469e-06
ical 0.0019931793212890625
▁op 1.0458984375
io 0.044921875
ids 0.0211029052734375
▁and 2.208984375
▁medical 1.396484375
▁mar 0.0374755859375
iju 0.0002751350402832031
ana 5.137920379638672e-05
▁were 0.56201171875
▁with 7.34375
dra 0.062286376953125
wn 1.239776611328125e-05
▁from 0.27734375
▁the 0.1729736328125
▁analysis 2.37109375
▁in 4.81640625
▁the 1.2509765625
▁research 4.40234375
. 1.0478515625
▁Therefore 4.71484375
, 0.01486968994140625
▁it 3.845703125
▁is 1.2822265625
▁not 2.849609375
▁possible 0.7373046875
▁to 0.00807952880859375
▁compreh 5.96875
ens 0.1219482421875
ively 0.014312744140625
▁compare 1.4833984375
▁patients 5.01171875
▁taking 3.888671875
▁medic 4.05859375
ations 0.5791015625
▁with 1.328125
▁those 0.92333984375
▁who 0.77294921875
▁do 1.4345703125
▁not 0.0041656494140625
. 0.67041015625
▁The 1.4150390625
▁study 1.828125
▁conducted 4.3046875
▁a 1.705078125
▁correlation 6.3359375
▁type 9.2265625
▁of 0.2288818359375
▁research 0.90625
▁with 3.4921875
▁variable 8.640625
▁measures 5.15234375
. 0.93603515625
▁For 4.6796875
▁example 1.451171875
, 0.001445770263671875
▁the 1.2431640625
▁survey 5.21875
▁showed 5.11328125
▁that 0.72998046875
▁the 1.826171875
▁ratio 6.31640625
▁of 0.0772705078125
▁female 3.9296875
▁patients 0.94287109375
▁was 1.2587890625
▁remark 8.09375
ably 0.0001595020294189453
▁higher 0.216064453125
▁in 2.35546875
▁the 0.43994140625
▁op 3.4609375
i 3.37109375
ates 0.01302337646484375
▁group 0.1810302734375
▁compared 2.638671875
▁to 0.041015625
▁the 0.56103515625
▁MM 0.155517578125
▁group 0.317138671875
. 0.49365234375
▁It 2.14453125
▁evaluated 10.5703125
▁the 0.69140625
▁inter 6.671875
dep 2.498046875
end 0.00024318695068359375
ence 0.006893157958984375
▁of 0.54296875
▁various 3.498046875
▁factors 0.79150390625
▁that 2.732421875
▁affected 4.0234375
▁the 0.38623046875
▁physical 6.8828125
▁and 0.339111328125
▁emot 0.45361328125
ional 9.608268737792969e-05
▁condition 1.4267578125
▁of 0.07470703125
▁patients 0.8447265625
▁experien 3.9375
cing 0.0003592967987060547
▁chron 0.283447265625
ic 0.0002046823501586914
▁pain 0.01143646240234375
. 0.1441650390625
▁In 3.408203125
▁turn 4.51171875
, 0.0006732940673828125
▁people 6.8125
▁on 5.046875
▁op 1.7021484375
i 0.546875
ates 0.0017299652099609375
▁were 1.4189453125
▁more 0.99072265625
▁likely 0.3291015625
▁to 0.028472900390625
▁report 2.794921875
▁major 6.0234375
▁de 0.338623046875
press 0.7109375
ive 0.0022144317626953125
▁dis 0.98388671875
orders 1.6259765625
. 1.8525390625
▁The 1.771484375
▁question 5.62890625
na 1.0869140625
ires 0.00011599063873291016
▁used 2.51171875
▁different 7.00390625
▁variable 8.046875
▁measures 0.352294921875
▁to 1.8388671875
▁collect 2.693359375
▁information 1.57421875
. 1.505859375
▁For 1.4248046875
▁example 0.2470703125
, 0.0013856887817382812
▁it 3.615234375
▁included 2.416015625
▁compreh 8.203125
ensive 0.044647216796875
▁so 5.65234375
cio 0.0008282661437988281
- 0.292724609375
dem 0.145263671875
ographic 0.06976318359375
▁data 0.94677734375
: 4.9375
▁gender 2.0234375
, 0.04388427734375
▁age 0.28662109375
, 0.03753662109375
▁country 4.34375
, 2.673828125
▁type 4.5078125
▁of 0.057464599609375
▁residence 3.921875
▁( 2.646484375
urban 0.705078125
/ 1.3388671875
r 0.1607666015625
ural 0.0008883476257324219
), 0.169189453125
▁years 6.22265625
▁of 0.1622314453125
▁education 0.68359375
, 0.08984375
▁and 1.4609375
▁employ 2.5234375
ment 0.0017490386962890625
▁status 0.634765625
. 0.1854248046875
▁Pat 4.59765625
ients 0.0926513671875
▁were 1.4365234375
▁also 1.03515625
▁asked 0.59423828125
▁about 0.90673828125
▁their 0.6845703125
▁medical 2.455078125
▁history 0.56396484375
▁over 8.6015625
▁the 0.062225341796875
▁years 4.64453125
▁and 1.7236328125
▁the 1.5126953125
▁current 2.91796875
▁presence 4.94921875
▁of 0.0753173828125
▁any 2.103515625
▁severe 3.658203125
▁dise 1.947265625
ases 8.094310760498047e-05
▁such 4.34375
▁as 0.0009927749633789062
▁heart 2.5390625
▁failure 1.7822265625
, 0.282470703125
▁di 1.57421875
ab 0.0006432533264160156
etes 0.0023651123046875
, 0.06707763671875
▁ar 4.046875
th 0.13232421875
rit 0.0213165283203125
is 0.00418853759765625
, 0.0254058837890625
▁and 1.2080078125
▁so 0.81201171875
▁on 0.05413818359375
. 0.05377197265625
▁The 1.4619140625
▁third 6.953125
▁measure 3.689453125
▁of 2.19921875
▁the 0.53271484375
▁question 1.9091796875
naire 0.215576171875
▁was 1.203125
▁indicated 10.6875
▁by 1.1806640625
▁information 6.484375
▁on 2.05078125
▁any 5.4765625
▁twelve 14.2734375
- 0.210205078125
month 0.1500244140625
▁and 4.94921875
▁lifetime 0.64306640625
▁drug 3.234375
▁and 1.64453125
▁alco 0.1339111328125
hol 6.0558319091796875e-05
▁consumption 4.81640625
. 0.432373046875
▁In 3.228515625
▁addition 1.0888671875
, 0.2489013671875
▁the 1.0029296875
▁record 10.1484375
▁included 1.453125
▁a 2.716796875
▁pain 4.796875
▁measurement 5.00390625
▁scale 0.814453125
▁from 4.25390625
▁ 0.50341796875
0 0.296142578125
▁to 0.2362060546875
▁ 0.00616455078125
1 0.06683349609375
0 0.032623291015625
▁to 3.19140625
▁evaluate 1.412109375
▁dis 6.21875
com 0.13232421875
fort 0.001800537109375
▁feelings 8.25
▁during 4.08984375
▁the 0.30322265625
▁last 1.0771484375
▁month 1.802734375
. 0.237548828125
▁Among 6.046875
▁all 2.439453125
▁participants 2.072265625
▁in 3.951171875
▁the 0.193115234375
▁study 0.548828125
, 0.03814697265625
▁ 0.74658203125
4 1.908203125
2 2.333984375
. 1.1669921875
2 2.232421875
% 0.06719970703125
▁suffered 3.80078125
▁from 0.066650390625
▁de 1.9501953125
pression 0.264404296875
, 0.93994140625
▁and 1.1728515625
▁ 0.1396484375
3 1.494140625
7 2.3515625
% 2.595703125
▁experienced 1.95703125
▁excess 6.9375
ive 0.02618408203125
▁anx 0.2386474609375
iety 0.0018310546875
. 0.4384765625
▁The 1.484375
▁pl 10.921875
ur 0.826171875
ality 0.0011415481567382812
▁of 0.113525390625
▁de 2.462890625
press 1.2509765625
ive 0.0260467529296875
▁dis 2.197265625
orders 0.07562255859375
▁among 2.896484375
▁patients 0.966796875
▁in 2.91015625
▁the 0.307373046875
▁op 0.4599609375
i 0.42529296875
ates 0.0018138885498046875
, 9.2578125
▁medical 3.892578125
▁mar 0.02484130859375
iju 0.000579833984375
ana 2.467632293701172e-05
, 0.224853515625
▁and 0.07733154296875
▁mixed 1.5830078125
▁OP 11.4609375
MM 4.33203125
▁groups 0.5478515625
▁number 9.265625
ed 0.01983642578125
▁ 0.1590576171875
5 1.728515625
7 2.607421875
. 0.46630859375
1 2.580078125
%, 0.197509765625
▁ 0.0031604766845703125
2 2.01953125
2 2.705078125
. 0.1021728515625
3 2.259765625
%, 0.0494384765625
▁and 0.05560302734375
▁ 0.0017805099487304688
5 2.12890625
1 2.07421875
. 0.1595458984375
4 1.955078125
%, 0.1500244140625
▁respectively 0.0186004638671875
. 0.28857421875
▁The 1.162109375
▁pl 3.611328125
ur 0.00688934326171875
ality 4.1961669921875e-05
▁of 0.021240234375
▁anx 0.453369140625
iety 0.0157470703125
▁contained 11.0625
▁ 0.21728515625
4 1.12890625
8 2.3828125
. 0.16552734375
4 2.203125
% 2.08984375
▁among 2.41015625
▁OP 5.15234375
▁patients 6.0234375
, 0.2802734375
▁ 0.08050537109375
2 0.912109375
1 2.470703125
. 0.1060791015625
5 2.11328125
% 0.024139404296875
▁among 0.42822265625
▁MM 0.10284423828125
▁patients 0.346923828125
, 0.0182037353515625
▁and 0.014312744140625
▁ 0.0254974365234375
3 1.369140625
8 1.9208984375
. 0.12408447265625
7 2.208984375
% 0.0115509033203125
▁among 0.184814453125
▁OP 1.98828125
MM 0.1292724609375
▁participants 3.365234375
. 0.2509765625
▁Pat 4.546875
ients 0.0157928466796875
▁who 1.990234375
▁took 2.22265625
▁strong 9.578125
▁op 0.671875
i 0.80615234375
ates 0.002994537353515625
▁were 1.2265625
▁t 10.28125
ended 1.048828125
▁to 0.00780487060546875
▁place 9.9765625
▁their 2.05078125
▁pain 1.1064453125
▁on 1.9013671875
▁a 0.58203125
▁scale 1.7763671875
▁of 0.376953125
▁ 0.110107421875
9 2.494140625
▁to 2.208984375
▁ 0.0106964111328125
1 0.0046539306640625
0 0.005046844482421875
▁( 2.787109375
Fe 1.671875
ing 0.0023136138916015625
old 0.0003249645233154297
▁et 0.0141143798828125
▁al 0.0008897781372070312
., 0.00891876220703125
▁ 0.0011949539184570312
2 0.00014698505401611328
0 2.3245811462402344e-05
1 0.002197265625
7 0.007476806640625
). 0.00955963134765625
▁They 3.44921875
▁were 1.75
▁also 1.2744140625
▁an 9.5234375
gu 4.58203125
ished 0.07757568359375
▁em 5.91796875
otion 0.0007147789001464844
ally 0.0006132125854492188
▁and 1.16015625
▁react 7.42578125
ed 0.0236053466796875
▁rad 9.0546875
ically 0.0007619857788085938
▁neg 4.7265625
atively 0.0011949539184570312
▁to 0.1995849609375
▁almost 5.37890625
▁all 1.583984375
▁survey 3.79296875
▁questions 0.2293701171875
. 0.30810546875
▁Pat 2.771484375
ients 0.00457763671875
▁who 1.1806640625
▁took 1.62890625
▁only 4.48046875
▁MM 0.39453125
▁or 2.98046875
▁mixed 2.384765625
▁medic 1.4619140625
ations 0.21728515625
▁course 13.71875
▁had 2.48828125
▁a 1.333984375
▁significantly 2.775390625
▁more 3.470703125
▁stable 2.505859375
▁emot 0.79296875
ional 0.0007996559143066406
▁state 0.5693359375
▁and 1.2470703125
▁cop 6.66015625
ed 0.0280303955078125
▁with 0.34765625
▁pain 0.92529296875
▁more 1.8671875
▁manage 6.7890625
able 1.564453125
. 0.283447265625
▁One 5.5703125
▁of 0.458251953125
▁the 0.00836944580078125
▁major 2.873046875
▁limitations 2.888671875
▁is 3.193359375
▁the 0.56787109375
▁ins 4.703125
u 0.0726318359375
fficient 0.08013916015625
ly 3.51171875
▁high 2.984375
▁response 3.24609375
▁rate 0.10003662109375
, 2.62890625
▁ 4.34765625
5 1.7451171875
7 2.7265625
% 2.21484375
▁instead 6.03515625
▁of 0.0026950836181640625
▁ 0.490966796875
7 1.7021484375
0 0.43994140625
% 1.4970703125
▁( 2.197265625
Fe 0.64599609375
ing 0.0016088485717773438
old 0.00022780895233154297
▁et 0.01055908203125
▁al 0.0006632804870605469
., 0.006427764892578125
▁ 0.0011444091796875
2 9.40561294555664e-05
0 8.118152618408203e-05
1 0.0004687309265136719
7 0.0027523040771484375
). 0.0108489990234375
▁It 1.787109375
▁can 3.24609375
▁be 0.69384765625
▁fairly 8.2890625
▁explained 1.7421875
▁by 0.199462890625
▁the 0.287841796875
▁weak 7.3359375
▁focus 7.04296875
▁of 0.685546875
▁respond 5.58984375
ents 0.10028076171875
▁who 3.630859375
▁have 3.814453125
▁overcome 8.2265625
▁severe 2.0234375
▁pain 0.5283203125
▁sens 7.69921875
ations 0.193603515625
▁and 0.951171875
▁de 4.74609375
press 0.78271484375
ive 0.042755126953125
▁episodes 2.326171875
. 0.45458984375
▁It 2.734375
▁is 0.7802734375
▁not 2.509765625
▁clear 3.60546875
▁how 1.9453125
▁to 3.330078125
▁use 4.98046875
▁these 2.70703125
▁statistics 4.109375
, 3.123046875
▁as 0.6982421875
▁they 1.8466796875
▁still 5.09375
▁may 5.0859375
▁be 1.1923828125
▁relevant 6.21875
▁for 1.75
▁the 1.9814453125
▁overall 4.85546875
▁analysis 2.572265625
. 0.8837890625
